[1]
Tuấn, N.A., Hoà, N.T.T., Quảng, L.V. and Thanh, V.H. 2026. First – line Afatinib treatment outcomes in stage IV non – small cell lung cancer harboring uncommon EGFR mutations at Vietnam National Cancer Hospital. Journal of Medical Research. 204, 7 (Aug. 2026), 448-458. DOI:https://doi.org/10.52852/tcncyh.v204i7.5438.